ArticleCancer research communications2023

Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor-positive Breast Cancer.

Yu-Chen Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.